Impressions from Arab Health Exhibition 2024: A Breakthrough Moment for Synergotron

At the Arab Health Exhibition 2024 in Dubai, Synergotron reached an important international milestone by presenting its proprietary Hybrid Plasma Technology in the prestigious Innov8 section dedicated to emerging startups and innovation.

For Synergotron, this was more than a product presentation. It was an opportunity to introduce a broader technology vision: a new non-invasive platform combining multiple physical energy modalities into one coordinated system architecture. Healeex, the company’s first commercial wellness product, was presented as the first practical expression of this platform.

A Global Platform for a New Technology Vision

Representing Synergotron, Dr. Emil Barić and Dr. Domagoj Prebeg presented the core concept behind Hybrid Plasma Technology — a proprietary technology platform based on the coordinated use of multiple physical energy modalities, including cold plasma, electromagnetic impulses, light-based stimulation, microcurrents, acoustic waves, and sonic microvibrations.

The presentation highlighted Synergotron’s long-term research and development work in non-invasive physical technologies, with a focus on how different energy-based modalities may be integrated into compact, user-oriented systems.

Rather than presenting Hybrid Plasma Technology as a single-product concept, Synergotron introduced it as a platform with potential relevance across wellness, performance, research, and future regulated development pathways.

Healeex as the First Commercial Expression

As the first commercial product based on Hybrid Plasma Technology, Healeex was introduced as a non-invasive wellness device designed to support general wellbeing, relaxation, body-care routines, and everyday comfort.

This distinction was central to the presentation. Healeex represents Synergotron’s current wellness-focused commercial application, while Hybrid Plasma Technology represents the broader technology foundation behind the company’s long-term innovation strategy.

Healeex was not presented as a medical device, nor as a product for diagnosis, treatment, cure, prevention, monitoring, or mitigation of disease. Its current positioning remains strictly within general wellness and non-medical use.

Strategic Conversations and International Interest

Synergotron’s presence at Arab Health 2024 created opportunities for meaningful conversations with international organizations, companies, investors, innovation platforms, and ecosystem partners.

Discussions included potential collaboration, technology positioning, market entry frameworks, product design, scaling considerations, regional innovation initiatives, and future development pathways. Among the conversations and connections were exchanges with organizations and representatives including Dedalus, Rowad Medical Services, Asiarath, NEOM, Wild Group and Franz Aigner, Pilar Fernandez from i-Expand, and Code Accelerator from Saudi Arabia.

These conversations reflected growing international interest in non-invasive, energy-based technologies and created new perspectives for Synergotron’s future growth.

More Than a Product Showcase

Arab Health 2024 provided Synergotron with valuable insight into global innovation trends, partner expectations, and the evolving intersection between wellness, technology, human performance, and future health-tech development.

The event confirmed that there is increasing interest in practical, portable, and non-invasive technology solutions designed for modern lifestyles. It also reinforced the importance of clear regulatory positioning: separating today’s wellness applications from future research, validation, and regulated development pathways.

For Synergotron, this distinction is essential. The company’s current commercial products are governed by their official classification, documentation, intended use, and applicable safety instructions. Any future regulated applications of Hybrid Plasma Technology would require formal validation, certification, and regulatory approval.

Building the Next Chapter

Synergotron’s participation at Arab Health 2024 marked an important step in the company’s international journey. It gave the team the opportunity to present Hybrid Plasma Technology to a global audience, introduce Healeex as its first wellness product, and open conversations with partners interested in the future of non-invasive energy-based innovation.

The experience strengthened Synergotron’s commitment to science-informed, user-centered development and long-term research. It also confirmed the value of presenting the company not only through a single product, but through the broader platform vision behind it.

Synergotron will continue building international partnerships, expanding market engagement, and investing in research and development. Healeex remains the company’s first wellness-focused commercial product, while Hybrid Plasma Technology continues to represent a broader platform for future innovation.

We are grateful for the recognition, conversations, and opportunities created at Arab Health 2024, and we look forward to the next chapter of Synergotron’s international journey.

Note: This article is provided for general informational and media purposes only and is subject to Synergotron’s Terms and Conditions and General Disclaimer, available in the footer of this website.

---

Note: This article is provided for general informational and media purposes only and is subject to Synergotron’s Terms and Conditions and General Disclaimer, available in the footer of this website.